Skip to content
ETopical – Lifestyle
Author:
Palvella Therapeutics Inc.
Palvella Therapeutics Strengthens QTORIN™ Pitavastatin Intellectual Property with Yale-Licensed U.S. Patent Providing Protection into 2043
May 27, 2026
←
Previous Page
1
2
3